10-45303927-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004297.3(OR13A1):c.496G>T(p.Val166Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000233 in 1,461,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004297.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR13A1 | NM_001004297.3 | c.496G>T | p.Val166Leu | missense_variant | 4/4 | ENST00000553795.6 | NP_001004297.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR13A1 | ENST00000553795.6 | c.496G>T | p.Val166Leu | missense_variant | 4/4 | 6 | NM_001004297.3 | ENSP00000451950.1 | ||
OR13A1 | ENST00000374401.3 | c.496G>T | p.Val166Leu | missense_variant | 4/4 | 6 | ENSP00000363522.2 | |||
OR13A1 | ENST00000536058.1 | c.496G>T | p.Val166Leu | missense_variant | 3/3 | 6 | ENSP00000438657.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248460Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134904
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461348Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 726988
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2024 | The c.496G>T (p.V166L) alteration is located in exon 4 (coding exon 1) of the OR13A1 gene. This alteration results from a G to T substitution at nucleotide position 496, causing the valine (V) at amino acid position 166 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at